How Conor McGregor’s ALP Nicotine Pouch Campaign At Turning Point Brands (TPB) Has Changed Its Investment Story

Turning Point Brands Inc

Turning Point Brands Inc

TPB

0.00

  • Earlier this week, ALP, a nicotine pouch brand owned by Turning Point Brands, announced a partnership with global combat sports figure Conor McGregor to front a broad 360-degree marketing campaign across broadcast, digital, social, and experiential channels.
  • This collaboration links ALP to McGregor’s substantial fan base and pop culture presence, potentially amplifying the brand’s reach as Turning Point Brands pushes deeper into modern oral and direct-to-consumer categories.
  • We’ll now examine how this high-profile Conor McGregor partnership could influence Turning Point Brands’ modern oral growth narrative and broader investment case.

Find 49 companies with promising cash flow potential yet trading below their fair value.

Turning Point Brands Investment Narrative Recap

To own Turning Point Brands, you need to believe its Modern Oral portfolio can keep gaining share while funding heavier marketing and distribution without eroding profitability. The Conor McGregor ALP campaign could aid that growth push in the near term, but it does not remove key risks such as higher SG&A, intense competitive promotions, or potential regulatory shocks that still hang over the category.

The most relevant recent update alongside this partnership is management’s decision on 7 May 2026 to raise Modern Oral 2026 gross and net sales guidance to US$280–300 million and US$210–225 million. That new guidance sharpens the focus on Modern Oral execution as the primary catalyst, making the effectiveness and cost of campaigns like ALP’s McGregor tie-up especially important for investors watching margin trends and category share.

Yet investors should also recognise how exposed this higher-growth story is to possible changes in nicotine pouch regulation and flavor rules that could...

Turning Point Brands' narrative projects $636.7 million revenue and $72.1 million earnings by 2029. This requires 11.2% yearly revenue growth and about a $13.9 million earnings increase from $58.2 million today.

Uncover how Turning Point Brands' forecasts yield a $132.50 fair value, a 47% upside to its current price.

Exploring Other Perspectives

TPB 1-Year Stock Price Chart
TPB 1-Year Stock Price Chart

Four fair value estimates from the Simply Wall St Community range from about US$40 to US$159 per share, showing wide differences in individual expectations. Against that backdrop, TPB’s heavier Modern Oral investment and rising marketing spend around ALP highlight how execution and category regulation could meaningfully influence which of these scenarios proves closer to reality, so it is worth considering several viewpoints.

Explore 4 other fair value estimates on Turning Point Brands - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Turning Point Brands research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Turning Point Brands research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Turning Point Brands' overall financial health at a glance.

Seeking Other Investments?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

  • Outshine the giants: these 13 early-stage AI stocks could fund your retirement.
  • AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.